Medicenna Therapeutics Corp. (MDNA:TSX) closed at $0.450 on October 16, 2026, up 2.27% on the day. The stock trades 77.2% below its 52-week high of $1.97 and 34.3% above its 52-week low of $0.335. Over the past year, it lost 50.0%. Medicenna Therapeutics Corp. is part of the Life Sciences sector (Biotechnology).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +3.45% | +11.11% | +28.57% | -25.00% | -50.00% |
In 252 trading sessions since October 16, 2025, MDNA closed higher on 89 days (35%). Its best day was October 24, 2025 (+49.06%) and its worst was May 14, 2026 (-15.15%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.
Medicenna Therapeutics Corp is a clinical stage immuno-oncology company developing novel first-in-class, Interleukin-4 Empowered Cytokines (IL4-ECs) that specifically target the Interleukin-4 Receptor (IL4R).
Find more stocks like MDNA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.